Obesity Care in Canada:

Weight-loss medications like Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are transforming obesity care — but their high cost keeps many Canadians from accessing them. In Canada, these life-changing treatments can cost $250–$600 per month, and most insurance plans still don’t provide coverage. Dr. Ehud Ur, Professor of Medicine at UBC, explores the growing gap between innovation and affordability, and highlights financial assistance programs such as Novo Nordisk Care, My Mounjaro, and My Zepbound that can help patients manage out-of-pocket costs. Learn how Canada can move toward equitable access to effective obesity treatments.